Jpmorgan Chase & Co »

Acadia Pharmaceuticals, Inc. C mn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Acadia Pharmaceuticals, Inc. C mn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Acadia Pharmaceuticals, Inc. C mn

Tip: Access up to 7 years of quarterly data

All positions including Acadia Pharmaceuticals, Inc. C mn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acadia Pharmaceuticals, Inc. C mn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $142k 7.7k 18.49
2023-09-30 $4.0M 192k 20.84
2022-06-30 $1.4M 103k 14.09
2021-03-31 $271k 11k 25.81
2020-12-31 $561k 11k 53.43
2019-12-31 $3.2M 74k 42.78

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Acadia Pharmaceuticals, Inc. C mn

Simplex Trading
Worth Venture Partners
Jane Street
Group One Trading
Jpmorgan Chase & Co

View all funds holding Acadia Pharmaceuticals, Inc. C mn